Progression of putaminal degeneration in multiple system atrophy: A serial diffusion MR study

NeuroImage

Volumn 31, Issue 1, 2006, Pages 240-245

  Seppi, Klaus ^a   Schocke, Michael F H ^a   Mair, Katherina J ^a   Esterhammer, Regina ^a   Scherfler, Christoph ^a   Geser, Felix ^a   Kremser, Christian ^a   Boesch, Sylvia ^a   Jaschke, Werner ^a   Poewe, Werner ^a   Wenning, Gregor K ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Diffusion imaging; Magnetic resonance imaging, MRI; MSA; Multiple system atrophy; Parkinson's disease, PD

Indexed keywords

ADULT; AGED; ARTICLE; BASAL GANGLION; BRAIN ATROPHY; BRAIN DEGENERATION; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; DISEASE COURSE; DISEASE SEVERITY; GLOBUS PALLIDUS; HUMAN; IMAGE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PRIORITY JOURNAL; PUTAMEN; SHY DRAGER SYNDROME;

AGED; CAUDATE NUCLEUS; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLOBUS PALLIDUS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; NERVE DEGENERATION; NEUROLOGIC EXAMINATION; PARKINSONIAN DISORDERS; PUTAMEN; STATISTICS; STRIATONIGRAL DEGENERATION;

EID: 33646570005     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2005.12.006     Document Type: Article

References (37)

1. Antonini A., Leenders K.L., Vontobel P., Maguire R.P., Missimer J., Psylla M., and Gunther I. Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease. Brain 120 Pt. 12 (1997) 2187-2195
2. Bhattacharya K., Saadia D., Eisenkraft B., Yahr M., Olanow W., Drayer B., and Kaufmann H. Brain magnetic resonance imaging in multiple-system atrophy and Parkinson disease: a diagnostic algorithm. Arch. Neurol. 59 (2002) 835-842
3. Brenneis C., Seppi K., Schocke M.F., Muller J., Luginger E., Bosch S., Loscher W.N., Buchel C., Poewe W., and Wenning G.K. Voxel-based morphometry detects cortical atrophy in the Parkinson variant of multiple system atrophy. Mov. Disord. 18 (2003) 1132-1138
4. Davie C.A., Wenning G.K., Barker G.J., Tofts P.S., Kendall B.E., Quinn N., McDonald W.I., Marsden C.D., and Miller D.H. Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy. Ann. Neurol. 37 (1995) 204-210
5. Does M.D., Zhong J., and Gore J.C. In vivo measurement of ADC change due to intravascular susceptibility variation. Magn. Reson. Med. 41 (1999) 236-240
6. Eckert T., Sailer M., Kaufmann J., Schrader C., Peschel T., Bodammer N., Heinze H.J., and Schoenfeld M.A. Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging. NeuroImage 21 (2004) 229-235
7. Federico F., Simone I.L., Lucivero V., Iliceto G., De Mari M., Giannini P., Mezzapesa D.M., Tarantino A., and Lamberti P. Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders. Mov. Disord. 12 (1997) 903-909
8. Ghaemi M., Hilker R., Rudolf J., Sobesky J., and Heiss W.D. Differentiating multiple system atrophy from Parkinson's disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging. J. Neurol., Neurosurg. Psychiatry 73 (2002) 517-523
9. Gilman S., Low P., Quinn N., Albanese A., Ben Shlomo Y., Fowler C., Kaufmann H., Klockgether T., Lang A., Lantos P., Litvan I., Mathias C., Oliver E., Robertson D., Schatz I., and Wenning G. Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology. Clin. Auton. Res. 8 (1998) 359-362
10. Hierholzer J., Cordes M., Venz S., Schelosky L., Harisch C., Richter W., Keske U., Hosten N., Maurer J., Poewe W., and Felix R. Loss of dopamine-D2 receptor binding sites in Parkinsonian plus syndromes. J. Nucl. Med. 39 (1998) 954-960
11. Horimoto Y., Aiba I., Yasuda T., Ohkawa Y., Katayama T., Yokokawa Y., Goto A., and Ito Y. Longitudinal MRI study of multiple system atrophy-When do the findings appear, and what is the course?. J. Neurol. 249 (2002) 847-854
12. Hughes A.J., Daniel S.E., Kilford L., and Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J. Neurol., Neurosurg. Psychiatry 55 (1992) 181-184
13. Kennan R.P., Zhong J., and Gore J.C. Effects of susceptibility variations on the apparent diffusion measured by NMR. In: Le Bihan D., and Rosen B. (Eds). MR Imaging of Perfusion and Diffusion (1995), Raven Press, New York, NY 110-131
14. Klockgether T., Faiss J., Poremba M., and Dichgans J. The development of infratentorial atrophy in patients with idiopathic cerebellar ataxia of late onset: a CT study. J. Neurol. 237 (1990) 420-423
15. Kraft E., Trenkwalder C., and Auer D.P. T2*-weighted MRI differentiates multiple system atrophy from Parkinson's disease. Neurology 59 (2002) 1265-1267
16. Lantos P.L. The definition of multiple system atrophy: a review of recent developments. J. Neuropathol. Exp. Neurol. 57 (1998) 1099-1111
17. Le Bihan D. Looking into the functional architecture of the brain with diffusion MRI. Nat. Rev. Neurosci. 4 (2003) 469-480
18. Muller J., Wenning G.K., Jellinger K., McKee A., Poewe W., and Litvan I. Progression of Hoehn and Yahr stages in Parkinsonian disorders: a clinicopathologic study. Neurology 55 (2000) 888-891
19. Pirker W., Djamshidian S., Asenbaum S., Gerschlager W., Tribl G., Hoffmann M., and Brucke T. Progression of dopaminergic degeneration in Parkinson's disease and atypical parkinsonism: a longitudinal beta-CIT SPECT study. Mov. Disord. 17 (2002) 45-53
20. Saito Y., Matsuoka Y., Takahashi A., and Ohno Y. Survival of patients with multiple system atrophy. Intern. Med. 33 (1994) 321-325
21. Schocke M.F., Seppi K., Esterhammer R., Kremser C., Jaschke W., Poewe W., and Wenning G.K. Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD. Neurology 58 (2002) 575-580
22. Schocke M.F., Seppi K., Esterhammer R., Kremser C., Mair K.J., Czermak B.V., Jaschke W., Poewe W., and Wenning G.K. Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease. NeuroImage 21 (2004) 1443-1451
23. Schrag A., Kingsley D., Phatouros C., Mathias C.J., Lees A.J., Daniel S.E., and Quinn N.P. Clinical usefulness of magnetic resonance imaging in multiple system atrophy. J. Neurol., Neurosurg. Psychiatry 65 (1998) 65-71
24. Schrag A., Good C.D., Miszkiel K., Morris H.R., Mathias C.J., Lees A.J., and Quinn N.P. Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology 54 (2000) 697-702
25. Schulz J.B., Klockgether T., Petersen D., Jauch M., Muller-Schauenburg W., Spieker S., Voigt K., and Dichgans J. Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT. J. Neurol., Neurosurg. Psychiatry 57 (1994) 1047-1056
26. Schulz J.B., Skalej M., Wedekind D., Luft A.R., Abele M., Voigt K., Dichgans J., and Klockgether T. Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy. Ann. Neurol. 45 (1999) 65-74
27. Seppi K., Schocke M.F., Esterhammer R., Kremser C., Brenneis C., Mueller J., Boesch S., Jaschke W., Poewe W., and Wenning G.K. Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy. Neurology 60 (2003) 922-927
28. Seppi K., Schocke M.F., Donnemiller E., Esterhammer R., Kremser C., Scherfler C., Diem A., Jaschke W., Wenning G.K., and Poewe W. Comparison of diffusion-weighted imaging and [(123)I]IBZM-SPECT for the differentiation of patients with the Parkinson variant of multiple system atrophy from those with Parkinson's disease. Mov. Disord. 19 (2004) 1438-1445
29. Seppi K., Yekhlef F., Diem A., Luginger W.E., Mueller J., Tison F., Quinn N.P., Poewe W., and Wenning G.K. Progression of parkinsonism in multiple system atrophy. J. Neurol. 252 (2005) 91-96
30. Stern M.B., Braffman B.H., Skolnick B.E., Hurtig H.I., and Grossman R.I. Magnetic resonance imaging in Parkinson's disease and parkinsonian syndromes. Neurology 39 (1989) 1524-1526
31. Testa D., Filippini G., Farinotti M., Palazzini E., and Caraceni T. Survival in multiple system atrophy: a study of prognostic factors in 59 cases. J. Neurol. 243 (1996) 401-404
32. Watanabe H., Saito Y., Terao S., Ando T., Kachi T., Mukai E., Aiba I., Abe Y., Tamakoshi A., Doyu M., Hirayama M., and Sobue G. Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. Brain 125 (2002) 1070-1083
33. Wenning G.K., Ben Shlomo Y., Magalhaes M., Daniel S.E., and Quinn N.P. Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. Brain 117 Pt. 4 (1994) 835-845
34. Wenning G.K., Tison F., Ben-Shlomo Y., Daniel S.E., and Quinn N.P. Multiple system atrophy: a review of 203 pathologically proven cases. Mov. Disord. 12 (1997) 133-147
35. Wenning G.K., Seppi K., Tison F., and Jellinger K. A novel grading scale for striatonigral degeneration (multiple system atrophy). J. Neural Transm. 109 (2002) 307-320
36. Wenning G.K., Colosimo C., Geser F., and Poewe W. Multiple system atrophy. Lancet Neurol. 3 (2004) 93-103
37. Zhong J., Kennan R.P., and Gore J.C. Effects of susceptibility variations on NMR measurements of diffusion. J. Mag. Reson. 95 (1991) 267-280